Inhibrx IncNASDAQ:INBX
- LAST PRICE34.7000
- TODAY'S CHANGE (%)0.2100 (0.6089%)
- Bid / Lots34.4100/ 6
- Ask / Lots34.5400/ 2
- Open / Previous Close34.6000 / 34.4900
- Day Range
- 52 Week Range
- Volume967,426
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INBX |
|---|---|---|
| 09:32 ET | 8189 | 34.52 |
| 09:34 ET | 100 | 34.565 |
| 09:36 ET | 500 | 34.6 |
| 09:38 ET | 473 | 34.61 |
| 09:39 ET | 400 | 34.6 |
| 09:41 ET | 100 | 34.6 |
| 09:43 ET | 800 | 34.58 |
| 09:45 ET | 100 | 34.6 |
| 09:48 ET | 2390 | 34.59 |
| 09:50 ET | 1100 | 34.565 |
| 09:52 ET | 200 | 34.59 |
| 09:54 ET | 100 | 34.57 |
| 09:56 ET | 16455 | 34.59 |
| 09:57 ET | 400 | 34.586 |
| 09:59 ET | 2500 | 34.525 |
| 10:01 ET | 6307 | 34.53 |
| 10:03 ET | 900 | 34.575 |
| 10:06 ET | 616 | 34.55 |
| 10:08 ET | 589 | 34.5752 |
| 10:10 ET | 1143 | 34.58 |
| 10:12 ET | 819 | 34.59 |
| 10:14 ET | 140 | 34.59 |
| 10:15 ET | 200 | 34.6 |
| 10:17 ET | 400 | 34.61 |
| 10:19 ET | 820 | 34.63 |
| 10:21 ET | 200 | 34.65 |
| 10:24 ET | 200 | 34.65 |
| 10:26 ET | 200 | 34.68 |
| 10:28 ET | 1262 | 34.61 |
| 10:30 ET | 319 | 34.61 |
| 10:32 ET | 100 | 34.6 |
| 10:33 ET | 100 | 34.61 |
| 10:35 ET | 305 | 34.6 |
| 10:37 ET | 100 | 34.595 |
| 10:46 ET | 100 | 34.63 |
| 10:48 ET | 100 | 34.61 |
| 10:51 ET | 300 | 34.62 |
| 10:55 ET | 200 | 34.63 |
| 10:57 ET | 200 | 34.655 |
| 11:02 ET | 500 | 34.64 |
| 11:04 ET | 765 | 34.64 |
| 11:08 ET | 19909 | 34.63 |
| 11:09 ET | 100 | 34.63 |
| 11:11 ET | 1163 | 34.63 |
| 11:13 ET | 1391 | 34.6 |
| 11:15 ET | 100 | 34.61 |
| 11:18 ET | 100 | 34.61 |
| 11:20 ET | 200 | 34.58 |
| 11:22 ET | 786 | 34.58 |
| 11:24 ET | 100 | 34.575 |
| 11:26 ET | 100 | 34.56 |
| 11:27 ET | 400 | 34.59 |
| 11:29 ET | 200 | 34.6 |
| 11:31 ET | 200 | 34.59 |
| 11:33 ET | 204 | 34.6 |
| 11:36 ET | 300 | 34.615 |
| 11:38 ET | 1112 | 34.615 |
| 11:40 ET | 100 | 34.62 |
| 11:42 ET | 300 | 34.61 |
| 11:44 ET | 200 | 34.61 |
| 11:45 ET | 200 | 34.625 |
| 11:47 ET | 200 | 34.635 |
| 11:49 ET | 200 | 34.64 |
| 11:51 ET | 452 | 34.64 |
| 11:54 ET | 100 | 34.65 |
| 11:56 ET | 200 | 34.65 |
| 11:58 ET | 200 | 34.63 |
| 12:00 ET | 200 | 34.65 |
| 12:02 ET | 50054 | 34.63 |
| 12:03 ET | 200 | 34.64 |
| 12:05 ET | 500 | 34.645 |
| 12:07 ET | 200 | 34.645 |
| 12:09 ET | 500 | 34.65 |
| 12:12 ET | 202 | 34.68 |
| 12:18 ET | 772 | 34.67 |
| 12:20 ET | 209 | 34.7 |
| 12:23 ET | 1900 | 34.685 |
| 12:27 ET | 100 | 34.66 |
| 12:30 ET | 100 | 34.66 |
| 12:32 ET | 100 | 34.66 |
| 12:34 ET | 200 | 34.6955 |
| 12:36 ET | 1648 | 34.695 |
| 12:39 ET | 684 | 34.67 |
| 12:41 ET | 100 | 34.68 |
| 12:43 ET | 6292 | 34.63 |
| 12:45 ET | 100 | 34.63 |
| 12:50 ET | 600 | 34.65 |
| 12:52 ET | 300 | 34.66 |
| 12:54 ET | 6333 | 34.7 |
| 12:56 ET | 3143 | 34.69 |
| 12:57 ET | 300 | 34.65 |
| 12:59 ET | 217 | 34.635 |
| 01:03 ET | 100 | 34.6375 |
| 01:06 ET | 248543 | 34.7 |
| 01:08 ET | 2245 | 34.64 |
| 01:10 ET | 400 | 34.62 |
| 01:12 ET | 1026 | 34.6 |
| 01:14 ET | 1458 | 34.6 |
| 01:15 ET | 200 | 34.59 |
| 01:17 ET | 115 | 34.59 |
| 01:19 ET | 200 | 34.61 |
| 01:21 ET | 400 | 34.6 |
| 01:24 ET | 4151 | 34.65 |
| 01:26 ET | 3439 | 34.5992 |
| 01:32 ET | 200 | 34.59 |
| 01:33 ET | 50400 | 34.59 |
| 01:35 ET | 1988 | 34.55 |
| 01:37 ET | 291 | 34.565 |
| 01:39 ET | 500 | 34.56 |
| 01:42 ET | 1360 | 34.58 |
| 01:44 ET | 100 | 34.585 |
| 01:48 ET | 100 | 34.61 |
| 01:50 ET | 300 | 34.6 |
| 01:51 ET | 100 | 34.59 |
| 01:53 ET | 400 | 34.6 |
| 01:55 ET | 954 | 34.6 |
| 01:57 ET | 100 | 34.6 |
| 02:02 ET | 600 | 34.575 |
| 02:04 ET | 474 | 34.57 |
| 02:06 ET | 200 | 34.57 |
| 02:08 ET | 100 | 34.57 |
| 02:09 ET | 100 | 34.57 |
| 02:11 ET | 218 | 34.58 |
| 02:13 ET | 200 | 34.57 |
| 02:15 ET | 400 | 34.58 |
| 02:18 ET | 400 | 34.575 |
| 02:20 ET | 200 | 34.575 |
| 02:24 ET | 100 | 34.57 |
| 02:26 ET | 610 | 34.56 |
| 02:27 ET | 200 | 34.57 |
| 02:29 ET | 582 | 34.58 |
| 02:31 ET | 300 | 34.59 |
| 02:33 ET | 2828 | 34.6 |
| 02:36 ET | 100 | 34.59 |
| 02:42 ET | 100 | 34.61 |
| 02:45 ET | 300 | 34.58 |
| 02:47 ET | 111 | 34.61 |
| 02:49 ET | 100 | 34.61 |
| 02:51 ET | 100 | 34.6 |
| 02:54 ET | 100 | 34.61 |
| 03:00 ET | 790 | 34.61 |
| 03:03 ET | 100 | 34.61 |
| 03:05 ET | 100 | 34.62 |
| 03:07 ET | 100 | 34.62 |
| 03:09 ET | 358 | 34.62 |
| 03:12 ET | 500 | 34.655 |
| 03:14 ET | 640 | 34.665 |
| 03:16 ET | 400 | 34.665 |
| 03:18 ET | 1398 | 34.64 |
| 03:21 ET | 2600 | 34.65 |
| 03:23 ET | 11144 | 34.58 |
| 03:25 ET | 480 | 34.62 |
| 03:27 ET | 400 | 34.64 |
| 03:32 ET | 200 | 34.64 |
| 03:34 ET | 700 | 34.62 |
| 03:36 ET | 300 | 34.63 |
| 03:38 ET | 3326 | 34.65 |
| 03:39 ET | 482 | 34.66 |
| 03:41 ET | 9267 | 34.65 |
| 03:43 ET | 600 | 34.67 |
| 03:45 ET | 200 | 34.67 |
| 03:48 ET | 300 | 34.67 |
| 03:50 ET | 1060 | 34.68 |
| 03:52 ET | 3138 | 34.69 |
| 03:54 ET | 22853 | 34.73 |
| 03:56 ET | 10948 | 34.725 |
| 03:57 ET | 11593 | 34.715 |
| 03:59 ET | 238761 | 34.7 |
May 10, 2024
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off, from 6:36PM ET on Friday May 10, 2024 by Dow Jones
6:36PM ET on Friday May 10, 2024 by Dow JonesPress Release: Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off, from 6:36PM ET on Friday May 10, 2024 by Dow Jones
6:36PM ET on Friday May 10, 2024 by Dow JonesSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWN, INBX, AVRO, from 1:50PM ET on Friday May 10, 2024 by Dow Jones
1:50PM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
May 8, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inhibrx Inc | 1.8B | -6.5x | --- |
Fusion Pharmaceuticals Inc | 1.8B | -15.2x | --- |
Keros Therapeutics Inc | 1.9B | -10.2x | --- |
NewAmsterdam Pharma Company NV | 1.8B | -7.4x | --- |
Syndax Pharmaceuticals Inc | 1.7B | -6.3x | --- |
Sana Biotechnology Inc | 1.9B | -5.7x | --- |
Company Information
Inhibrx, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing a broad pipeline of novel biologic therapeutic candidates. The Company’s pipeline is focused on oncology and orphan diseases. Its clinical pipeline includes therapeutic candidates, such as INBRX-101, and INBRX-109. INBRX-101 is an engineered recombinant human alpha-1 antitrypsin fragment crystallizable (AAT-Fc) fusion protein therapeutic candidate that the Company is developing for the treatment of patients with Alpha-1 Antitrypsin Deficiency (AATD) and acute Graft-versus -host-disease (aGvHD). AATD is an inherited disease that causes an increased risk of developing pulmonary disease defined by progressive loss of lung tissue and function and is associated with decreased life expectancy. INBRX-109 is an engineered tetravalent therapeutic candidate targeting death-receptor 5 (DR5), a TNFRSF member, also known as tumor necrosis factor-related apoptosis-inducing ligand or TRAIL receptor 2.
Contact Information
- Headquarters
- 11025 N. Torrey Pines Road, Suite 200LA JOLLA, CA, United States 92037
- Phone
- 858-795-4220
- Fax
- 302-636-5454
Executives
- Chairman of the Board of Director, President, Chief Executive Officer, Co-Founder
- Mark Lappe
- Co-Founder, Chief Scientific Officer
- Brendan Eckelman
- Chief Financial Officer
- Kelly Deck
- Independent Director
- Douglas Forsyth
- Independent Director
- Jon Kayyem
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
|---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 52.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.82 |
EPS | $-5.35 |
Book Value | $0.92 |
P/E Ratio | -6.5x |
Price/Sales (TTM) | 1,017.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,980.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
